Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xifeng Wu

Showing results (21-30 of 583) with videos related to

Pageof 59
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|May 16, 2009
Pharmacogenomics of platinum-based chemotherapy in NSCLCMichelle A T Hildebrandt, Jian Gu, Xifeng Wu
Methods in Molecular Biology (Clifton, N.J.)|October 27, 2004
Mutagen-induced chromatid breakage as a marker of cancer riskXifeng Wu, Yun-Ling Zheng, T C Hsu
Methods in Molecular Medicine|November 1, 2002
Myeloperoxidase promoter region polymorphism and lung cancer riskXifeng Wu, Matthew B Schabath, Margaret R Spitz
Methods in Molecular Biology (Clifton, N.J.)|March 14, 2014
Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer riskXifeng Wu, Yun-Ling Zheng, T C Hsu
BMC Cancer|December 17, 2009
Risk of urinary bladder cancer: a case-control analysis of industry and occupationAdrian Cassidy, Wei Wang, Xifeng Wu, et al.
BJU International|November 28, 2008
Epidemiology and genetic susceptibility to bladder cancerXifeng Wu, Martine M Ros, Jian Gu, et al.
Methods in Molecular Medicine|November 1, 2002
Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer riskXifeng Wu, He Yu, Nimisha Makan, et al.
Oncogene|August 24, 2004
Genetic susceptibility to tobacco-related cancerXifeng Wu, Hua Zhao, Rebecca Suk, et al.
Gynecologic Oncology|September 22, 2007
Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivityJ Salvador Saldivar, Xifeng Wu, Michele Follen, et al.
Cancer Metastasis Reviews|December 18, 2009
Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applicationsXifeng Wu, Michelle A T Hildebrandt, David W Chang
Pageof 59

Showing results (21-30 of 583) with videos related to

Sort By:
Pageof 59
Expert Opinion on Drug Metabolism & Toxicology|May 16, 2009
Pharmacogenomics of platinum-based chemotherapy in NSCLCMichelle A T Hildebrandt, Jian Gu, Xifeng Wu
Methods in Molecular Biology (Clifton, N.J.)|October 27, 2004
Mutagen-induced chromatid breakage as a marker of cancer riskXifeng Wu, Yun-Ling Zheng, T C Hsu
Methods in Molecular Medicine|November 1, 2002
Myeloperoxidase promoter region polymorphism and lung cancer riskXifeng Wu, Matthew B Schabath, Margaret R Spitz
Methods in Molecular Biology (Clifton, N.J.)|March 14, 2014
Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer riskXifeng Wu, Yun-Ling Zheng, T C Hsu
BMC Cancer|December 17, 2009
Risk of urinary bladder cancer: a case-control analysis of industry and occupationAdrian Cassidy, Wei Wang, Xifeng Wu, et al.
BJU International|November 28, 2008
Epidemiology and genetic susceptibility to bladder cancerXifeng Wu, Martine M Ros, Jian Gu, et al.
Methods in Molecular Medicine|November 1, 2002
Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer riskXifeng Wu, He Yu, Nimisha Makan, et al.
Oncogene|August 24, 2004
Genetic susceptibility to tobacco-related cancerXifeng Wu, Hua Zhao, Rebecca Suk, et al.
Gynecologic Oncology|September 22, 2007
Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivityJ Salvador Saldivar, Xifeng Wu, Michele Follen, et al.
Cancer Metastasis Reviews|December 18, 2009
Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applicationsXifeng Wu, Michelle A T Hildebrandt, David W Chang
Pageof 59